Search

Your search keyword '"Dyslipidemias mortality"' showing total 260 results

Search Constraints

Start Over You searched for: Descriptor "Dyslipidemias mortality" Remove constraint Descriptor: "Dyslipidemias mortality"
260 results on '"Dyslipidemias mortality"'

Search Results

1. The relationship between serum HDL-cholesterol, cardiovascular disease and mortality in community-based people with type 2 diabetes: the Fremantle Diabetes Study phase 2.

2. Association of PCSK9 inhibitors with mortality: insights from a retrospective cohort analysis.

3. Effects of icosapent ethyl according to baseline residual risk in patients with atherosclerotic cardiovascular disease: results from REDUCE-IT.

4. The U-shaped association between remnant cholesterol and risk of all-cause and cardiovascular deaths in diabetic adults: Findings from NHANES 1999-2018.

5. Statin therapy and cardiovascular protection in type 2 diabetes: The role of baseline LDL-Cholesterol levels. A systematic review and meta-analysis of observational studies.

6. Combination of low- or moderate-intensity statin and ezetimibe vs. high-intensity statin monotherapy on primary prevention of cardiovascular disease and all-cause death: a propensity-matched nationwide cohort study.

7. Lipid profile and mortality in patients with pulmonary thromboembolism; a systematic review and meta-analysis.

8. Oxidative balance score and associations with dyslipidemia and mortality among US adults: A mortality follow-up study of a cross-sectional cohort.

9. Early administration of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors in patients with acute coronary syndrome: a systematic review and meta-analysis.

10. Potential impact of blood cholesterol guidelines on statin treatment in the U.S. population using interrupted time series analysis.

11. Association between hyperuricemia and the risk of mortality in patients with osteoarthritis: A study based on the National Health and Nutrition Examination Survey database.

12. Association of Use and Dose of Lipid-Lowering Therapy Post Acute Myocardial Infarction With 5-Year Survival in Older Adults.

13. Effect of blood lipid variability on mortality in patients with type 2 diabetes: a large single-center cohort study.

14. Remnant Cholesterol and Cardiovascular Mortality in Patients With Type 2 Diabetes and Incident Diabetic Nephropathy.

15. Atherogenic index of plasma is associated with major adverse cardiovascular events in patients with type 2 diabetes mellitus.

16. Effects of Statin Therapy and Dose on Cardiovascular and Limb Outcomes in Peripheral Arterial Disease: A Systematic Review and Meta-analysis.

17. Department of Veterans Affairs (VA) and U.S. Department of Defense (DoD) guidelines for management of dyslipidemia and cardiovascular disease risk reduction: Putting evidence in context.

18. Low-density lipoprotein cholesterol levels are associated with poor clinical outcomes in COVID-19.

19. HDL-C, longitudinal change and risk of mortality in a Chinese cohort study.

20. What Do US Physicians and Patients Think About Lipid-Lowering Therapy and Goals of Treatment? Results From the GOULD Registry.

21. Association of dyslipidemia with the severity and mortality of coronavirus disease 2019 (COVID-19): a meta-analysis.

22. Compliance in Primary Prevention With Statins and Associations With Cardiovascular Risk and Death in a Low-Risk Population With Type 2 Diabetes Mellitus.

23. Preadmission Statin Therapy and Clinical Outcome in Hospitalized Patients With COVID-19: An Italian Multicenter Observational Study.

24. Role of Statins in Coronavirus-Related Disease (COVID-19): A Retrospective Cohort Study in Northern Italy.

25. Effects of Anthocyanins on Vascular Health.

26. The cost-effectiveness of intensive low-density lipoprotein cholesterol lowering in people with peripheral artery disease.

27. Poor Metabolic Health Increases COVID-19-Related Mortality in the UK Biobank Sample.

28. Lipoprotein(a) Reduction With Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: A Systematic Review and Meta-analysis.

29. Lipid profile and prognosis in patients with coronary heart disease: a meta-analysis of prospective cohort studies.

30. Clinical outcomes with high-intensity statins according to atherothrombotic risk stratification after acute myocardial infarction: The FAST-MI registries.

31. Postponement of cardiovascular outcomes by statin use: A systematic review and meta-analysis of randomized clinical trials.

32. Independent association of atherogenic dyslipidaemia with all-cause mortality in individuals with type 2 diabetes and modifying effect of gender: a prospective cohort study.

33. Lipid levels and the risk of hemorrhagic stroke: A dose-response meta-analysis.

34. Association between serum matrix metalloproteinase-9 and poor prognosis in acute ischemic stroke patients: The role of dyslipidemia.

35. Differentiating characteristics of patients with asthma in the severe acute respiratory syndrome coronavirus 2 infection.

36. Statin Use and In-Hospital Mortality in Patients With Diabetes Mellitus and COVID-19.

37. Role of Lipid-Lowering Therapy in Low-Density Lipoprotein Cholesterol Goal Attainment: Focus on Patients With Acute Coronary Syndrome.

38. Statin Prescription Rates, Adherence, and Associated Clinical Outcomes Among Women with PAD and ICVD.

39. Statin adherence and risk of all-cause, cancer, and cardiovascular mortality among dyslipidemia patients: A time-dependent analysis.

40. Lipid-lowering nutraceuticals update on scientific evidence.

41. Association of circulating PCSK9 concentration with cardiovascular metabolic markers and outcomes in stable coronary artery disease patients with or without diabetes: a prospective, observational cohort study.

42. Effects and Safety of Statin and Ezetimibe Combination Therapy in Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis.

43. Triglyceride to high-density lipoprotein cholesterol ratio and risk of atherosclerotic cardiovascular disease in a Chinese population.

44. High-intensity lipid-lowering regimens in patients with stable coronary artery disease: the intriguing question of all-cause mortality.

45. Gender differences in the impact of metabolic syndrome components on mortality in older people: A systematic review and meta-analysis.

46. A Randomized Clinical Trial of the Efficacy and Safety of Interferon β-1a in Treatment of Severe COVID-19.

47. A Retrospective Controlled Cohort Study of the Impact of Glucocorticoid Treatment in SARS-CoV-2 Infection Mortality.

48. Association of serum cholesterol with coronary heart disease mortality during 50-year follow-up in ten cohorts of the seven countries study.

49. Issues for the management of people with diabetes and COVID-19 in ICU.

50. Efficacy of more intensive lipid-lowering therapy on cardiovascular diseases: a systematic review and meta-analysis.

Catalog

Books, media, physical & digital resources